Literature DB >> 7732559

Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation.

C A Schmidt1, H Oettle, R Peng, P Neuhaus, G Blumhardt, R Lohmann, F Wilborn, K Osthoff, J Oertel, H Timm.   

Abstract

We compared the value of PCR on plasma with PCR on buffy coat leukocytes, Ag assay, and the determination of IgM antibodies by ELISA for the diagnosis and follow-up of cytomegalovirus infection. Thirty patients were followed after liver transplantation (LTX). We compared the tests to assess their clinical usefulness. Fourteen of 30 (46%) patients were both positive in plasma and buffy coat PCR and Ag test. Sixteen patients were negative in both procedures. There was a 97.2% concordance between PCRs done from plasma or buffy coat. The concordance of results of PCR and Ag test in single samples was 94.3%. Discordant results were found in 5.6% of samples. Discordance was observed in the early and the late phase of CMV infection and was due to positive PCRs preceding positive Ag tests for 1-3 weeks in one-half of the patients. IgM antibodies were first observed after a median period of 8 weeks (range, 6-11 weeks) after LTX. Positive PCRs and Ag tests preceded clinical manifestation of CMV disease by a 1 week median (range, 0-3 weeks), whereas positive IgM ELISAs occurred after a median period of 2.5 weeks (range, 0-4 weeks) after the onset of CMV disease. The sensitivity and specificity of both PCR and Ag test were identical, 100% and 76%, respectively. However, for the IgM ELISA, the sensitivity was only 66%, and the specificity was 84%. In conclusion, plasma or buffy coat PCR and Ag test are equally reliable procedures for early detection and monitoring of CMV infection. PCR can become positive earlier than the Ag test, but it is technically more demanding to perform. The demonstration of IgM antibodies is of little practical help because an antibody response occurs too late in relation to infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732559

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence.

Authors:  R Boom; C Sol; J Weel; Y Gerrits; M de Boer; P Wertheim-van Dillen
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Detection of human cytomegalovirus DNA by real-time quantitative PCR.

Authors:  A Nitsche; N Steuer; C A Schmidt; O Landt; H Ellerbrok; G Pauli; W Siegert
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?

Authors:  N Singh; V L Yu
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

Review 4.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 5.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  Peripheral blood leukocytes and serum nested polymerase chain reaction are complementary methods for monitoring active cytomegalovirus infection in transplant patients.

Authors:  Pd Andrade; Mt Fioravanti; Ebv Anjos; C De Oliveira; Dm Albuquerque; Scb Costa
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

7.  Detection of CMV DNA in bone marrow transplant recipients: plasma versus leucocyte polymerase chain reaction.

Authors:  P C Woo; S K Lo; K Y Yuen; J S Peiris; H Siau; E K Chiu; R H Liang; T K Chan
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

8.  Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay.

Authors:  D N Chernoff; R C Miner; B S Hoo; L P Shen; R J Kelso; D Jekic-McMullen; J P Lalezari; S Chou; W L Drew; J A Kolberg
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

9.  Quantitation of cytomegalovirus (hCMV) DNA and beta-actin DNA by duplex real-time fluorescence PCR in solid organ (liver) transplant recipients.

Authors:  Joachim Hänfler; Karl Anton Kreuzer; Katja Laurisch; Nada Rayes; Peter Neuhaus; Christian Andreas Schmidt; Helmut Oettle
Journal:  Med Microbiol Immunol       Date:  2003-01-30       Impact factor: 3.402

Review 10.  Cytomegalovirus infection in transplant recipients.

Authors:  Luiz Sergio Azevedo; Lígia Camera Pierrotti; Edson Abdala; Silvia Figueiredo Costa; Tânia Mara Varejão Strabelli; Silvia Vidal Campos; Jéssica Fernandes Ramos; Acram Zahredine Abdul Latif; Nadia Litvinov; Natalya Zaidan Maluf; Helio Hehl Caiaffa Filho; Claudio Sergio Pannuti; Marta Heloisa Lopes; Vera Aparecida dos Santos; Camila da Cruz Gouveia Linardi; Maria Aparecida Shikanai Yasuda; Heloisa Helena de Sousa Marques
Journal:  Clinics (Sao Paulo)       Date:  2015-07-01       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.